← Leaderboards
Stephen Clement
Georgetown University
$171,774
Attributed
$171,774
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$171,774 · 5
By mechanism
M01$171,774 · 5
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Paul Aisen$0
- Joseph Alphonso Bellanti$750,336
- Nazrat Mirza$828,843
- Vanita Aroda$2,879,955
Others in their field
Top investigators on “Noninsulin Dependent Diabetes Mellitus”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$69,532,406
- Katherine M Detre · University Of Pittsburgh At Pittsburgh$33,288,043
- Mark Andrew Espeland · Wake Forest University Health Sciences$18,466,667
- C Ronald Kahn · Joslin Diabetes Center$17,946,199
- F. Xavier Pi-Sunyer · Columbia University Health Sciences$13,600,448
- David M Nathan · Massachusetts Institute Of Technology$13,352,064
Research focus
Noninsulin Dependent Diabetes MellitusDiabetes Mellitus TherapyDiabetic AngiopathyClinical ResearchHuman SubjectOmega 3 Fatty AcidPatient Oriented ResearchHuman Therapy EvaluationDrug Screening /EvaluationDiet TherapyInsulinInsulin Dependent Diabetes MellitusInsulin Sensitivity /ResistanceMetabolism Disorder ChemotherapyNutrition Related TagPrediabetic StateAfrican AmericanRacial /Ethnic DifferenceBlood GlucoseBody Physical CharacteristicCardiovascular Disorder PreventionClinical TrialsDietary SupplementsGlucose Clamp Technique
Grant awards (5)
PIOGLITAZONE ON PROGRESSION OFIMPAIRED GLUCOSE TOLERANCE TO TYPE 2 DIABETES$92,356
M01 · FY2005 · RR
LANTUS, OMEGA-3 FATTY ACIDS &CVD IN PEOPLE W/IFG, IGT$51,993
M01 · FY2005 · RR
LANTUS VS NPH INSULIN IN PRE &POST-OPERATIVE INSULIN DEPENDENT DIABETIC PATIENT$24,268
M01 · FY2005 · RR
Lantus vs standard care &omega-3 vs placebo in IFG, IGT, type II diabet mellit$2,105
M01 · FY2004 · RR
Nateglinide vs placebo before 3 meals on insulin sensitivity in African American$1,052
M01 · FY2004 · RR